Mohammadreza Pakyari, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hamartoma Syndrome, Multiple | 1 | 2023 | 114 | 0.830 |
Why?
|
Fibroma | 1 | 2023 | 190 | 0.800 |
Why?
|
Skin Transplantation | 2 | 2016 | 1083 | 0.440 |
Why?
|
Graft Survival | 3 | 2016 | 3818 | 0.370 |
Why?
|
Immune Tolerance | 2 | 2016 | 2300 | 0.350 |
Why?
|
Fibroblasts | 5 | 2018 | 4139 | 0.330 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 2 | 2018 | 117 | 0.270 |
Why?
|
Wound Healing | 2 | 2018 | 2802 | 0.260 |
Why?
|
Bandages | 2 | 2016 | 269 | 0.230 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5820 | 0.230 |
Why?
|
Sweet Syndrome | 1 | 2023 | 58 | 0.220 |
Why?
|
Graft Rejection | 1 | 2016 | 4446 | 0.210 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2023 | 184 | 0.210 |
Why?
|
Primary Myelofibrosis | 1 | 2023 | 209 | 0.190 |
Why?
|
PTEN Phosphohydrolase | 1 | 2023 | 1114 | 0.150 |
Why?
|
Detergents | 1 | 2018 | 235 | 0.150 |
Why?
|
Kynurenic Acid | 1 | 2016 | 44 | 0.130 |
Why?
|
Dermatitis | 1 | 2018 | 201 | 0.130 |
Why?
|
Nanofibers | 1 | 2016 | 66 | 0.130 |
Why?
|
Skin | 3 | 2018 | 4482 | 0.130 |
Why?
|
Polymethyl Methacrylate | 1 | 2016 | 131 | 0.130 |
Why?
|
Alopecia Areata | 1 | 2017 | 127 | 0.120 |
Why?
|
Mice, Inbred BALB C | 3 | 2018 | 6210 | 0.110 |
Why?
|
Mice, Inbred C3H | 3 | 2017 | 915 | 0.090 |
Why?
|
Recurrence | 1 | 2023 | 8470 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2299 | 0.090 |
Why?
|
Wound Infection | 1 | 2013 | 245 | 0.090 |
Why?
|
Anti-Infective Agents, Local | 1 | 2013 | 247 | 0.090 |
Why?
|
Debridement | 1 | 2013 | 493 | 0.090 |
Why?
|
Psoriasis | 1 | 2018 | 939 | 0.090 |
Why?
|
Hydrogen Peroxide | 1 | 2013 | 728 | 0.080 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4321 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5670 | 0.060 |
Why?
|
Dendritic Cells | 1 | 2016 | 2746 | 0.060 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 22154 | 0.060 |
Why?
|
Coculture Techniques | 2 | 2017 | 1341 | 0.050 |
Why?
|
Burns | 1 | 2013 | 1864 | 0.050 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18234 | 0.040 |
Why?
|
Mutation | 1 | 2023 | 30044 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20092 | 0.040 |
Why?
|
Animals | 7 | 2018 | 168388 | 0.040 |
Why?
|
Mice | 4 | 2018 | 81474 | 0.040 |
Why?
|
Interleukin-23 | 1 | 2018 | 201 | 0.030 |
Why?
|
Injections, Intraperitoneal | 1 | 2016 | 412 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2017 | 276 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2017 | 5491 | 0.030 |
Why?
|
Rats, Long-Evans | 1 | 2016 | 383 | 0.030 |
Why?
|
Glycosaminoglycans | 1 | 2018 | 607 | 0.030 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2016 | 398 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2018 | 911 | 0.020 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2016 | 740 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 18962 | 0.020 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2016 | 1115 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2018 | 1726 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2016 | 1254 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2013 | 766 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4120 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4649 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2016 | 4810 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2018 | 5866 | 0.020 |
Why?
|
Humans | 5 | 2023 | 761326 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9180 | 0.020 |
Why?
|
Cell Movement | 1 | 2018 | 5202 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2018 | 11070 | 0.010 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2017 | 4576 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3075 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6389 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7390 | 0.010 |
Why?
|
Female | 5 | 2018 | 392485 | 0.010 |
Why?
|
Male | 4 | 2023 | 360621 | 0.010 |
Why?
|
Middle Aged | 1 | 2023 | 220774 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 54405 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 59196 | 0.000 |
Why?
|
Adult | 1 | 2013 | 221122 | 0.000 |
Why?
|